Quince Therapeutics
QNCX
QNCX
87 hedge funds and large institutions have $827M invested in Quince Therapeutics in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% more call options, than puts
Call options by funds: $473K | Put options by funds: $445K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 30
Holders
87
Holding in Top 10
2
Calls
$473K
Puts
$445K
Top Buyers
| 1 | +$38.8M | |
| 2 | +$4.93M | |
| 3 | +$3.61M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.56M |
| 5 |
PHAM
Pacific Heights Asset Management
San Francisco,
California
|
+$3.1M |
Top Sellers
| 1 | -$3.57M | |
| 2 | -$2.11M | |
| 3 | -$1.17M | |
| 4 |
Renaissance Technologies
New York
|
-$1.13M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$860K |